Masaki Yamada

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia

Masamichi Mori, Naoki Kaneko, Yoko Ueno et al. · Investigational New Drugs · 2017 · 254 citations · Full text

Medicine, Oncology, Pharmacology +16

Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals

Tetsuya Kimura, Shigeyuki Nada, Noriko Takegahara et al. · Nature Communications · 2016 · 176 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Structure‐guided identification of a new catalytic motif of oligosaccharyltransferase

Mayumi Igura, Nobuo Maita, Jun Kamishikiryo et al. · The EMBO Journal · 2007 · 165 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Enhancing Tolerance to Short-Chain Alcohols by Engineering the Escherichia coli AcrB Efflux Pump to Secrete the Non-native Substrate <i>n</i>-Butanol

Michael A. Fisher, Sergey Boyarskiy, Masaki Yamada et al. · ACS Synthetic Biology · 2013 · 121 citations

Life Sciences, Biotechnology, Microbiology +17

A comprehensive quantification method for eicosanoids and related compounds by using liquid chromatography/mass spectrometry with high speed continuous ionization polarity switching

Masaki Yamada, Yoshihiro Kita, Takahiro Kohira et al. · Journal of Chromatography B · 2015 · 85 citations

Pharmacy, Chemistry, Pharmaceutical Analysis +12